Project for Futuristic Surgical Training Receives CHF 12 Million in Funding

Project for Futuristic Surgical Training Receives CHF 12 Million in Funding

Surgical Training: Swiss Innovation Agency Innosuisse has awarded a grant of CHF 12 million over the next four years in support of the “PROFICIENCY” project for surgical simulation. The project initiates a paradigm shift in practical training in surgery: away from primary training in the operating room, towards standardized and proficiency-based surgical training curricula.

Thanks to technical advances in virtual and augmented reality, many surgical procedures can already be simulated with lifelike accuracy. However, practical training still frequently occurs in the operating room. The disadvantage of this form of training became obvious during the Covid 19 pandemic: surgical training was largely restricted or not possible at all in most hospitals during this time.

“With the ‘PROFICIENCY’ project, we want to advance simulator-based continuing education in surgery,” explains Prof. Bruno Schmied, M.D., Chief of Surgery at the Cantonal Hospital of St. Gallen. “The innovative continuing education program – analogous to the training and continuing education of pilots on flight simulators – will decisively improve surgical continuing education in open and minimally invasive surgery and initiate the desired paradigm shift to competence-oriented and didactically high-quality simulator-supported training.”

As a first decisive step, the project will design a modular curriculum that is aligned with the requirements of surgical societies and integrated on a digitally accessible learning platform. This standardized, evidence-based and performance-oriented training program will be taught using the latest didactic methods and empower surgeons to acquire skills through self-paced learning.

In a second major step, the consortium will develop innovative training tools for simulating different surgical scenarios, ranging from online virtual reality simulation, augmented box trainers, high-end simulators, to augmented-reality-enabled open surgery and immersive remote operation room participation.

“This flagship innovation project brings together the necessary medical, pedagogical and technical expertise to create the most advanced and comprehensive surgical training curriculum ever developed,” said Stefan Tuchschmid, PhD, co-CEO and founder of VirtaMed.

The consortium of project partners includes the Cantonal Hospital of St.Gallen, Lausanne University Hospital (CHUV), the University of Zurich with Balgrist University Hospital, ETH Zurich and Zurich University of Applied Sciences (ZHAW), as well as the companies VirtaMed AG, Microsoft Schweiz GmbH , ORamaVR S.A. and Atracsys LLC.

SourceVirtaMed

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”